Rifaximin

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

Retrieved on: 
Monday, September 25, 2023
Rifaximin, Bausch, BHC, Pomerantz, NYSE, Private investigator

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).

Key Points: 
  • NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).
  • The investigation concerns whether Bausch and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

BAUSCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bausch Health Companies, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 23, 2023
Class Action Lawsuit, Professional Services, Legal, Rifaximin, P.C, Loss, Telephone, Jeanne Eagels, BHC, Person, Complaint, District court, Court, NYSE, Bausch

Investors have until September 25, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 25, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Following the announcement, Bausch's stock price fell $3.50 per share, or 27.13%, to close at $9.40 per share on May 10, 2022.
  • Then, on July 28, 2022, Bausch issued an update on the Xifaxan patent dispute case between Bausch and Norwich, in which the court ruled that certain Bausch patents were invalid.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Bausch, and Applied Digital and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, September 18, 2023
Cloud, Ticketmaster, Pressure, P.C, Rifaximin, Music, Senate, Politico, Consumer, DOJ, LYV, BHC, United States Senate Judiciary Subcommittee on Competition Policy, Antitrust and Consumer Rights, Live Nation Entertainment, Complaint, Competition law, Congress, The New York Times, Applied Digital Data Systems, NPR, Defendant, Knowledge, Policy, Bausch Health, Letter, NYSE, News, Cryptocurrency, Audit, Bausch

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • For more information on the Live Nation class action go to: https://bespc.com/cases/LYV
    On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • For more information on the Bausch class action go to: https://bespc.com/cases/BHC
    Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
  • For more information on the Applied Digital class action go to: https://bespc.com/cases/APLD

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

Retrieved on: 
Sunday, September 17, 2023
Rifaximin, Bausch, BHC, Pomerantz, NYSE, Private investigator

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).

Key Points: 
  • NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).
  • The investigation concerns whether Bausch and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

BHC INVESTOR DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Case

Retrieved on: 
Saturday, September 16, 2023
CASE, Rifaximin, Probability, Bausch Health, Face, Bank statement, BHC, History, Complaint, SAN, CFO, Fraud, News, NYSE, Tobacco

The Bausch Health class action lawsuit further alleges that on May 4, 2021, Bausch Health discussed the leverage ratios of both Bausch Health and B+L, revealing that B+L would be stronger financially than Bausch Health post-spinoff.

Key Points: 
  • The Bausch Health class action lawsuit further alleges that on May 4, 2021, Bausch Health discussed the leverage ratios of both Bausch Health and B+L, revealing that B+L would be stronger financially than Bausch Health post-spinoff.
  • The Bausch Health class action lawsuit further alleges that on this news, the price of Bausch Health shares declined more than 11%.
  • The Bausch Health class action lawsuit alleges that on this news, the price of Bausch Health shares declined nearly 47%.
  • The Bausch Health class action lawsuit alleges that on this news, the price of Bausch Health shares declined more than 20%.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bausch, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, September 12, 2023
Cloud, Workforce, Rifaximin, P.C, Head, BHC, Complaint, Infinity, Applied Digital Data Systems, Maximization, Bausch Health, Hand, NYSE, Breast cancer, Pharmaceutical industry, Audit, Bausch

On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.

Key Points: 
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Following the announcement, Bausch's stock price fell $3.50 per share, or 27.13%, to close at $9.40 per share on May 10, 2022.
  • On July 24, 2023, Infinity announced that the merger had been terminated, because shareholders of the merging company voted against it.
  • For more information on the Infinity class action go to: https://bespc.com/cases/INFI

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

Retrieved on: 
Saturday, September 9, 2023
Rifaximin, LLP, Bausch, Pomerantz, NYSE, Private investigator

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).

Key Points: 
  • NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).
  • The investigation concerns whether Bausch and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Bausch, and Applied Digital and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 7, 2023
Cloud, Ticketmaster, Pressure, P.C, Rifaximin, Music, Senate, Politico, Consumer, DOJ, LYV, BHC, United States Senate Judiciary Subcommittee on Competition Policy, Antitrust and Consumer Rights, Live Nation Entertainment, Complaint, Competition law, Congress, The New York Times, Applied Digital Data Systems, NPR, Defendant, Knowledge, Policy, Bausch Health, Letter, NYSE, News, Cryptocurrency, Audit, Bausch

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • For more information on the Live Nation class action go to: https://bespc.com/cases/LYV
    On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • For more information on the Bausch class action go to: https://bespc.com/cases/BHC
    Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
  • For more information on the Applied Digital class action go to: https://bespc.com/cases/APLD

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against KeyCorp, Live Nation, and Bausch and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 2, 2023
Morgan Stanley, Defendant, Ticketmaster, P.C, Pressure, Rifaximin, Music, FY, Senate, NII, Politico, Consumer, DOJ, LYV, BHC, United States Senate Judiciary Subcommittee on Competition Policy, Antitrust and Consumer Rights, Live Nation Entertainment, KeyBank, Complaint, RBC Capital Markets, Silicon, Competition law, Congress, The New York Times, NPR, Knowledge, Policy, Letter, Signature Bank, NYSE, News, Conference, Silvergate Bank, Bank, Pharmaceutical industry, Cryptocurrency, Audit, Bausch

Key has repeatedly downplayed concerns regarding its liquidity while touting the effectiveness of its long-term liquidity strategy.

Key Points: 
  • Key has repeatedly downplayed concerns regarding its liquidity while touting the effectiveness of its long-term liquidity strategy.
  • The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • For more information on the Live Nation class action go to: https://bespc.com/cases/LYV
    On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • For more information on the Bausch class action go to: https://bespc.com/cases/BHC

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

Retrieved on: 
Friday, September 1, 2023
Rifaximin, LLP, Bausch, Pomerantz, NYSE, Private investigator

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).

Key Points: 
  • NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or the “Company”) (NYSE: BHC).
  • The investigation concerns whether Bausch and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On May 10, 2022, Bausch reports its financial results for the first quarter of 2022.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.